Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Accumulated Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Accumulated Expenses for 2 consecutive years, with $15.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Expenses changed N/A to $15.5 million in Q4 2025 year-over-year; TTM through Oct 2025 was $15.5 million, a N/A change, with the full-year FY2025 number at $13.8 million, up 52.32% from a year prior.
  • Accumulated Expenses was $15.5 million for Q4 2025 at Kestra Medical Technologies, up from $13.6 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $15.5 million in Q4 2025 to a low of $9.1 million in Q2 2024.